Oslo University Hospital, Ullevål
Oslo, NO-0424, Norway
NCT Number: NCT01232608
Diabetes mellitus (DM) is an important risk factor in the development of cardiovascular disease, and people with type 2 diabetes have a two- to four-fold increased risk for cardiovascular morbidity and mortality. Physical activity is a well established therapeutic modality for type 2 diabetes. In patients with coronary artery disease (CAD), several clinical trials have shown reduced mortality and reduced progression of atherosclerosis with lifestyle intervention including physical activity. But few studies have investigated the effect of physical training in patients suffering from both diseases.
The aim of this study is to investigate the effect of one year of organized physical exercise in patients with both coronary heart disease and type 2 diabetes on glucometabolic state and progression of atherosclerosis.
The project is a randomized, controlled, open study on physical exercise. 136 patients will be randomized at inclusion to a physical exercise group or a control group, the latter with "normal" follow-up and not discouraged form physical activity. The intervention period will be 12 months, and the physical training program will be developed and conducted in collaboration with Norwegian School of Sport Sciences. The inclusion of patients started summer 2010, the exercise program begins in September 2010 and the practical issues of the study is planned to end during spring 2012.
The main hypothesis is that physical exercise improves the glucometabolic state and reduces progression of atherosclerosis in patients with coronary heart disease and type 2 diabetes, and secondary that physical exercise induces favourable changes in cardiovascular risk factors, use of medication, and co-morbidity associated with diabetes.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Oslo, NO-0424, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
12 months of exercise training
Time frame: 12 months
Glucometabolic state is defined as: HbA1c, fasting insulin, fasting c-peptid, fasting blood glucose
Time frame: 12 months
Atherosclerosis will be assessed by measurements of:
Time frame: 12 months
Dyslipidemia will be measured by total cholesterol, HDL, LDL, fasting triglycerides and free fatty acids
Time frame: 12 months
Visceral obesity will be measured by waist circumference
Oslo University Hospital
Other
Acronym: EXCADI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00005487
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT06508437
Arterial Occlusive Diseases, Arteriosclerosis
Tours, France
View Trial DetailsNCT04382443
Acute Coronary Syndrome, Arterial Occlusive Diseases
Ciudad de Buenos Aires, Buenos Aires, Argentina
View Trial DetailsNCT05436977
Acute Coronary Syndrome, Arterial Occlusive Diseases
Bologna, Italy
View Trial Details